Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Marionneau, S.
Right arrow Articles by Le Pendu, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marionneau, S.
Right arrow Articles by Le Pendu, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Glycobiology, 2002, Vol. 12, No. 12 851-856
© 2002 Oxford University Press

Expression of histo-blood group A antigen increases resistance to apoptosis and facilitates escape from immune control of rat colon carcinoma cells

Séverine Marionneau, Béatrice Le Moullac-Vaidye and Jacques Le Pendu1

INSERM U419, Institut de Biologie, 9 Quai Moncousu, 44093 Nantes, France

A and B histo-blood group antigens are present on carcinoma cells at the early stages of cancerogenesis and tend to disappear at later stages, but it is not yet clear whether they take part to the process of tumor progression. To gain some insight into this issue, we used a rat colon carcinoma experimental model. To obtain expression of the A antigen, REG cells were cotransfected with the rat A enzyme cDNA and a rat {alpha}1,2fucosyltransferase cDNA, either FTA or FTB, whereas PRO cells that spontaneously have {alpha}1,2fucosyltransferase activity were only transfected with the A enzyme cDNA. All A antigen–expressing transfected cells derived from either REG FTA, REG FTB, or PRO parental cells were more resistant to apoptosis induced by either serum deprivation or heat shock than were their respective controls. When injected to syngeneic immunocompetent rats, A enzyme–transfected PRO cells formed tumors that grew faster than those formed by mock-transfected PRO cells. However, in immunodeficient SCID mice, no difference in growth could be observed between the two types of tumors, indicating that the faster tumor growth of the A antigen–positive cells in immunocompetent animals was due to their higher ability to escape immune control and that this was associated with their higher degree of resistance to apoptosis. These results might explain the slightly augmented incidence of carcinomas observed in A and B blood group individuals compared to O individuals.

1 To whom correspondence should be addressed; E-mail: jlependu@nantes.inserm.fr


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
K. Tsuboi, T. Asao, M. Ide, S. Hashimoto, K. Noguchi, Y. Kominato, A. R. Saniabadi, H. Kuwano, and S. Yazawa
{alpha}1,2Fucosylation Is a Superior Predictor of Postoperative Prognosis for Colorectal Cancer Compared with Blood Group A, B, or Sialyl Lewis X Antigen Generated within Colorectal Tumor Tissues
Ann. Surg. Oncol., June 1, 2007; 14(6): 1880 - 1889.
[Abstract] [Full Text] [PDF]


Home page
J. Dent. Res.Home page
E. Dabelsteen and S. Gao
ABO Blood-group Antigens in Oral Cancer
J. Dent. Res., January 1, 2005; 84(1): 21 - 28.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.